Methodological quality of studies
| Study | Method of randomisation performed | Treatment allocation concealed | Similarity groups baseline | Eligibility criteria specified | Blinding outcome assessor | Point estimates and measures of variability for primary outcome | Intention-to-treat analyses | Total |
|---|---|---|---|---|---|---|---|---|
| Adamsen et al25 | + | + | + | + | + | + | + | 7 |
| Courneya et al26 | + | + | + | + | + | + | + | 7 |
| Courneya et al27 | + | − | + | + | + | + | + | 6 |
| Courneya et al28 | + | + | + | + | − | + | + | 6 |
| Courneya et al29 | + | + | + | + | − | + | + | 6 |
| Dimeo et al30 | + | + | + | + | − | + | + | 6 |
| Goedendorp et al31 | + | + | + | + | − | + | + | 6 |
| Milne et al32 | + | + | + | + | − | + | + | 6 |
| Mutrie et al33 | + | + | + | + | − | + | + | 6 |
| Andersen et al34 | + | − | + | + | − | + | + | 5 |
| Cadmus et al35 | + | + | + | + | − | + | − | 5 |
| Streckmann et al36 | + | − | + | + | − | + | + | 5 |
| Oldervoll et al37 | + | − | + | + | − | + | − | 4 |
| Samuel et al38 | + | − | + | + | − | + | + | 4 |
| Henke et al39 | + | − | − | + | − | + | − | 3 |
| Monga et al40 | + | − | − | + | − | + | − | 3 |